• 文献检索
  • 文档翻译
  • 深度研究
  • 学术资讯
  • Suppr Zotero 插件Zotero 插件
  • 邀请有礼
  • 套餐&价格
  • 历史记录
应用&插件
Suppr Zotero 插件Zotero 插件浏览器插件Mac 客户端Windows 客户端微信小程序
定价
高级版会员购买积分包购买API积分包
服务
文献检索文档翻译深度研究API 文档MCP 服务
关于我们
关于 Suppr公司介绍联系我们用户协议隐私条款
关注我们

Suppr 超能文献

核心技术专利:CN118964589B侵权必究
粤ICP备2023148730 号-1Suppr @ 2026

文献检索

告别复杂PubMed语法,用中文像聊天一样搜索,搜遍4000万医学文献。AI智能推荐,让科研检索更轻松。

立即免费搜索

文件翻译

保留排版,准确专业,支持PDF/Word/PPT等文件格式,支持 12+语言互译。

免费翻译文档

深度研究

AI帮你快速写综述,25分钟生成高质量综述,智能提取关键信息,辅助科研写作。

立即免费体验

弥漫性脑桥内生型胶质瘤中驱动基因突变的时空同质性

Spatial and temporal homogeneity of driver mutations in diffuse intrinsic pontine glioma.

作者信息

Nikbakht Hamid, Panditharatna Eshini, Mikael Leonie G, Li Rui, Gayden Tenzin, Osmond Matthew, Ho Cheng-Ying, Kambhampati Madhuri, Hwang Eugene I, Faury Damien, Siu Alan, Papillon-Cavanagh Simon, Bechet Denise, Ligon Keith L, Ellezam Benjamin, Ingram Wendy J, Stinson Caedyn, Moore Andrew S, Warren Katherine E, Karamchandani Jason, Packer Roger J, Jabado Nada, Majewski Jacek, Nazarian Javad

机构信息

Department of Human Genetics, McGill University, Montreal, Québec, Canada H3A 1B1.

McGill University and Génome Québec Innovation Centre, Montreal, Québec, Canada H3A 0G1.

出版信息

Nat Commun. 2016 Apr 6;7:11185. doi: 10.1038/ncomms11185.

DOI:10.1038/ncomms11185
PMID:27048880
原文链接:https://pmc.ncbi.nlm.nih.gov/articles/PMC4823825/
Abstract

Diffuse Intrinsic Pontine Gliomas (DIPGs) are deadly paediatric brain tumours where needle biopsies help guide diagnosis and targeted therapies. To address spatial heterogeneity, here we analyse 134 specimens from various neuroanatomical structures of whole autopsy brains from nine DIPG patients. Evolutionary reconstruction indicates histone 3 (H3) K27M--including H3.2K27M--mutations potentially arise first and are invariably associated with specific, high-fidelity obligate partners throughout the tumour and its spread, from diagnosis to end-stage disease, suggesting mutual need for tumorigenesis. These H3K27M ubiquitously-associated mutations involve alterations in TP53 cell-cycle (TP53/PPM1D) or specific growth factor pathways (ACVR1/PIK3R1). Later oncogenic alterations arise in sub-clones and often affect the PI3K pathway. Our findings are consistent with early tumour spread outside the brainstem including the cerebrum. The spatial and temporal homogeneity of main driver mutations in DIPG implies they will be captured by limited biopsies and emphasizes the need to develop therapies specifically targeting obligate oncohistone partnerships.

摘要

弥漫性脑桥内在型胶质瘤(DIPG)是致命的儿童脑肿瘤,针吸活检有助于指导诊断和靶向治疗。为了解决空间异质性问题,我们分析了9例DIPG患者全脑尸检不同神经解剖结构的134个标本。进化重建表明,组蛋白3(H3)K27M(包括H3.2K27M)突变可能首先出现,并且在整个肿瘤及其扩散过程中,从诊断到终末期疾病,始终与特定的、高保真的必需伴侣相关,提示肿瘤发生存在相互需求。这些与H3K27M普遍相关的突变涉及TP53细胞周期(TP53/PPM1D)或特定生长因子途径(ACVR1/PIK3R1)的改变。后期致癌改变出现在亚克隆中,且常影响PI3K途径。我们的研究结果与肿瘤早期扩散至脑干以外包括大脑一致。DIPG主要驱动突变的时空同质性意味着它们将被有限的活检所捕获,并强调需要开发专门针对必需癌组蛋白伙伴关系的治疗方法。

https://cdn.ncbi.nlm.nih.gov/pmc/blobs/d0de/4823825/a7b47eab82f6/ncomms11185-f3.jpg
https://cdn.ncbi.nlm.nih.gov/pmc/blobs/d0de/4823825/c2c2da5a9385/ncomms11185-f1.jpg
https://cdn.ncbi.nlm.nih.gov/pmc/blobs/d0de/4823825/d5ad3537dfe4/ncomms11185-f2.jpg
https://cdn.ncbi.nlm.nih.gov/pmc/blobs/d0de/4823825/a7b47eab82f6/ncomms11185-f3.jpg
https://cdn.ncbi.nlm.nih.gov/pmc/blobs/d0de/4823825/c2c2da5a9385/ncomms11185-f1.jpg
https://cdn.ncbi.nlm.nih.gov/pmc/blobs/d0de/4823825/d5ad3537dfe4/ncomms11185-f2.jpg
https://cdn.ncbi.nlm.nih.gov/pmc/blobs/d0de/4823825/a7b47eab82f6/ncomms11185-f3.jpg

相似文献

1
Spatial and temporal homogeneity of driver mutations in diffuse intrinsic pontine glioma.弥漫性脑桥内生型胶质瘤中驱动基因突变的时空同质性
Nat Commun. 2016 Apr 6;7:11185. doi: 10.1038/ncomms11185.
2
Histopathological spectrum of paediatric diffuse intrinsic pontine glioma: diagnostic and therapeutic implications.儿童弥漫性脑桥内在型胶质瘤的组织病理学谱:诊断及治疗意义
Acta Neuropathol. 2014 Oct;128(4):573-81. doi: 10.1007/s00401-014-1319-6. Epub 2014 Jul 22.
3
ACVR1 R206H cooperates with H3.1K27M in promoting diffuse intrinsic pontine glioma pathogenesis.ACVR1 R206H 与 H3.1K27M 协同促进弥漫性内在脑桥神经胶质瘤的发病机制。
Nat Commun. 2019 Mar 4;10(1):1023. doi: 10.1038/s41467-019-08823-9.
4
Histone H3.3 K27M Accelerates Spontaneous Brainstem Glioma and Drives Restricted Changes in Bivalent Gene Expression.组蛋白 H3.3 K27M 加速自发性脑桥神经胶质瘤的发生,并驱动二价基因表达的受限变化。
Cancer Cell. 2019 Jan 14;35(1):140-155.e7. doi: 10.1016/j.ccell.2018.11.015. Epub 2018 Dec 27.
5
K27M mutation in histone H3.3 defines clinically and biologically distinct subgroups of pediatric diffuse intrinsic pontine gliomas.K27M 突变的组蛋白 H3.3 定义了具有临床和生物学特征的不同亚组的儿童弥漫性内在脑桥胶质瘤。
Acta Neuropathol. 2012 Sep;124(3):439-47. doi: 10.1007/s00401-012-0998-0. Epub 2012 Jun 3.
6
Clinicopathology of diffuse intrinsic pontine glioma and its redefined genomic and epigenomic landscape.弥漫性脑桥内在型胶质瘤的临床病理学及其重新定义的基因组和表观基因组格局
Cancer Genet. 2015 Jul-Aug;208(7-8):367-73. doi: 10.1016/j.cancergen.2015.04.008. Epub 2015 May 1.
7
Molecular landscape of pediatric diffuse intrinsic pontine gliomas: about 22 cases.小儿弥漫性脑桥内在型胶质瘤的分子图谱:约22例病例
J Neurooncol. 2017 Sep;134(2):465-467. doi: 10.1007/s11060-017-2523-8. Epub 2017 Jun 6.
8
TP53 wild-type/PPM1D mutant diffuse intrinsic pontine gliomas are sensitive to a MDM2 antagonist.TP53 野生型/PPM1D 突变弥漫性内在脑桥胶质瘤对 MDM2 拮抗剂敏感。
Acta Neuropathol Commun. 2021 Nov 3;9(1):178. doi: 10.1186/s40478-021-01270-y.
9
Histone H3F3A and HIST1H3B K27M mutations define two subgroups of diffuse intrinsic pontine gliomas with different prognosis and phenotypes.组蛋白H3F3A和HIST1H3B K27M突变定义了弥漫性脑桥内在型胶质瘤的两个亚组,它们具有不同的预后和表型。
Acta Neuropathol. 2015 Dec;130(6):815-27. doi: 10.1007/s00401-015-1478-0. Epub 2015 Sep 23.
10
TP53 Pathway Alterations Drive Radioresistance in Diffuse Intrinsic Pontine Gliomas (DIPG).TP53 通路改变导致弥漫性内在脑桥胶质瘤(DIPG)的放射抵抗。
Clin Cancer Res. 2019 Nov 15;25(22):6788-6800. doi: 10.1158/1078-0432.CCR-19-0126. Epub 2019 Sep 3.

引用本文的文献

1
Case Report: Application of drug sensitivity testing to identify personalized treatment options for an adolescent with diffuse midline glioma.病例报告:应用药敏试验为一名弥漫性中线胶质瘤青少年患者确定个性化治疗方案。
Front Oncol. 2025 Aug 7;15:1606575. doi: 10.3389/fonc.2025.1606575. eCollection 2025.
2
Vaccine therapies for glioma: clinical frontiers and potential breakthrough.胶质瘤的疫苗疗法:临床前沿与潜在突破
Front Oncol. 2025 Jun 25;15:1613332. doi: 10.3389/fonc.2025.1613332. eCollection 2025.
3
PALB2 deficiency may sensitize H3K27M-mutant pediatric HGG cells to BMN673/talazoparib.

本文引用的文献

1
Histone H3F3A and HIST1H3B K27M mutations define two subgroups of diffuse intrinsic pontine gliomas with different prognosis and phenotypes.组蛋白H3F3A和HIST1H3B K27M突变定义了弥漫性脑桥内在型胶质瘤的两个亚组,它们具有不同的预后和表型。
Acta Neuropathol. 2015 Dec;130(6):815-27. doi: 10.1007/s00401-015-1478-0. Epub 2015 Sep 23.
2
PIK3CA(H1047R) induces multipotency and multi-lineage mammary tumours.PIK3CA(H1047R) 诱导多能性和多谱系乳腺肿瘤。
Nature. 2015 Sep 3;525(7567):114-8. doi: 10.1038/nature14669. Epub 2015 Aug 12.
3
Relapsed neuroblastomas show frequent RAS-MAPK pathway mutations.
PALB2基因缺陷可能使H3K27M突变型儿童高级别胶质瘤细胞对BMN673/他拉唑帕尼敏感。
Front Oncol. 2025 Jun 30;15:1589396. doi: 10.3389/fonc.2025.1589396. eCollection 2025.
4
Serum metabolic profiling enables diagnosis, prognosis, and monitoring for brainstem gliomas.血清代谢谱分析有助于脑干胶质瘤的诊断、预后评估及监测。
Nat Commun. 2025 Jul 3;16(1):6108. doi: 10.1038/s41467-025-61163-9.
5
Diagnostic yield of intraoperative frozen sections obtained through robot-assisted stereotactic biopsy of brain lesions.通过机器人辅助立体定向脑病变活检获得的术中冰冻切片的诊断率。
Front Neurol. 2025 Jun 10;16:1544613. doi: 10.3389/fneur.2025.1544613. eCollection 2025.
6
Recent developments in peptide vaccines against Glioblastoma, a review and update.抗胶质母细胞瘤肽疫苗的最新进展:综述与更新
Mol Brain. 2025 Jun 13;18(1):50. doi: 10.1186/s13041-025-01221-x.
7
Histopathological grades as prognostic factors of H3 K27-altered diffuse midline glioma and their prediction using multiparametric MR imaging.组织病理学分级作为H3 K27改变的弥漫性中线胶质瘤的预后因素及其多参数磁共振成像预测
Neuroradiology. 2025 Jun 6. doi: 10.1007/s00234-025-03660-8.
8
A specific form of cPRC1 containing CBX4 is co-opted to mediate oncogenic gene repression in diffuse midline glioma.一种含有CBX4的特定形式的cPRC1被用于介导弥漫性中线胶质瘤中的致癌基因抑制。
Mol Cell. 2025 Jun 5;85(11):2110-2127.e7. doi: 10.1016/j.molcel.2025.04.026. Epub 2025 May 21.
9
Spatial analysis of a complete DIPG-infiltrated brainstem reveals novel ligand-receptor mediators of tumour-to-TME crosstalk.对完全被弥漫性内在脑桥胶质瘤(DIPG)浸润的脑干进行空间分析,揭示了肿瘤与肿瘤微环境(TME)相互作用的新型配体-受体介质。
Acta Neuropathol Commun. 2025 Feb 19;13(1):35. doi: 10.1186/s40478-025-01952-x.
10
Establishment of xenografts and methods to evaluate tumor burden for the three most frequent subclasses of pediatric-type diffuse high grade gliomas.小儿型弥漫性高级别胶质瘤三种最常见亚类的异种移植瘤建立及肿瘤负荷评估方法
J Neurooncol. 2025 May;172(3):599-611. doi: 10.1007/s11060-025-04954-w. Epub 2025 Feb 17.
复发性神经母细胞瘤常出现RAS-MAPK通路突变。
Nat Genet. 2015 Aug;47(8):864-71. doi: 10.1038/ng.3333. Epub 2015 Jun 29.
4
Fast and scalable inference of multi-sample cancer lineages.多样本癌症谱系的快速且可扩展推断
Genome Biol. 2015 May 6;16(1):91. doi: 10.1186/s13059-015-0647-8.
5
PhyloWGS: reconstructing subclonal composition and evolution from whole-genome sequencing of tumors.PhyloWGS:从肿瘤全基因组测序中重建亚克隆组成与进化
Genome Biol. 2015 Feb 13;16(1):35. doi: 10.1186/s13059-015-0602-8.
6
A standardized autopsy procurement allows for the comprehensive study of DIPG biology.标准化的尸检获取有助于对弥漫性内生性脑桥胶质瘤(DIPG)生物学进行全面研究。
Oncotarget. 2015 May 20;6(14):12740-7. doi: 10.18632/oncotarget.3374.
7
Deep sequencing of multiple regions of glial tumors reveals spatial heterogeneity for mutations in clinically relevant genes.对胶质肿瘤多个区域进行深度测序揭示了临床相关基因中突变的空间异质性。
Genome Biol. 2014 Dec 3;15(12):530. doi: 10.1186/s13059-014-0530-z.
8
Use of human embryonic stem cells to model pediatric gliomas with H3.3K27M histone mutation.利用人类胚胎干细胞对携带H3.3K27M组蛋白突变的小儿胶质瘤进行建模。
Science. 2014 Dec 19;346(6216):1529-33. doi: 10.1126/science.1253799. Epub 2014 Nov 20.
9
Moderated estimation of fold change and dispersion for RNA-seq data with DESeq2.使用DESeq2对RNA测序数据的倍数变化和离散度进行适度估计。
Genome Biol. 2014;15(12):550. doi: 10.1186/s13059-014-0550-8.
10
ExomeAI: detection of recurrent allelic imbalance in tumors using whole-exome sequencing data.外显子组人工智能:利用全外显子组测序数据检测肿瘤中复发性等位基因失衡
Bioinformatics. 2015 Feb 1;31(3):429-31. doi: 10.1093/bioinformatics/btu665. Epub 2014 Oct 8.